HUSSAIN IQBAL J (General Counsel) sold 5.4% of their position (6K shares) of CENTESSA PHARMACEUTICALS PLC on the open market
Open‑market sale worth $134.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/16/2025ACC: 0001470831-25-000263
Officer· General Counsel
Since May 2021
-6K
Net shares
Net seller
$134.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6K acquired · 12K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+6K
Price / share
$5.84
Trade value
$35.04K
% of position
5.7%
10/15/2025
105.39K→111.39K
Ordinary Shares
Direct
Shares
−6K
Price / share
$22.41
Trade value
$134.44K
% of position
5.4%
10/15/2025
111.39K→105.39K
Total
Net shares
+0.00
Net value
-$99.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 10/15/2025 | M · Option Exercise | +6K | $5.84 | $35.04K | 5.7% | 105.39K | 111.39K |
| Ordinary Shares Direct | 10/15/2025 | S · Sale | −6K | $22.41 | $134.44K | 5.4% | 111.39K | 105.39K |
| Total | +0.00 | -$99.40K | ||||||
Derivative Transactions1
Share Option (right to buy)
Direct
Converts to
Ordinary Shares
6K shares
Shares
−6K
Strike price
5.84
Held after
227.56K
Exercisable
—
10/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option (right to buy) Direct | Ordinary Shares6K shares | 10/15/2025 | M · Option Exercise | −6K | 5.84 | — | 227.56K |
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares
IndirectShares owned5.50K
Total
5.50K indirect5.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 5.50K | Indirect |
| Total | 5.50K | 5.50K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported